Janux Therapeutics Ownership 2024 | Who Owns Janux Therapeutics Now?
Institutional Ownership
3.82%
Insider Ownership
9.42%
Retail Ownership
86.76%
Institutional Holders
52.00
Janux Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 18.69% | 5.08% | 9,165,652 | - | - | 383,949,162 | Jun 30, 2024 |
| FMR LLC | 15.86% | 0.02% | 7,777,600 | 28,591 | 0.37% | 325,803,649 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 6.08% | 2.48% | 2,979,828 | -1,295,725 | -30.31% | 124,824,995 | Jun 30, 2024 |
| BLACKROCK INC. | 4.78% | 0.00% | 2,344,007 | 650,016 | 38.37% | 98,190,453 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.75% | 0.18% | 2,327,896 | -447,776 | -16.13% | 97,515,563 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 3.67% | 0.04% | 1,801,843 | -163,703 | -8.33% | 75,389,599 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 3.19% | 2.51% | 1,564,452 | 1,564,452 | 100.00% | 65,534,894 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.18% | 0.00% | 1,561,758 | 203,798 | 15.01% | 65,422,042 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 3.00% | 1.88% | 1,469,818 | 1,469,818 | 100.00% | 61,570,676 | Jun 30, 2024 |
| STATE STREET CORP | 2.86% | 0.00% | 1,401,234 | 1,001,767 | 250.78% | 58,697,692,000 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.14% | 2.54% | 1,050,000 | 300,000 | 40.00% | 43,984,500 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.71% | 1.50% | 840,219 | 455,974 | 118.67% | 35,196,774 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 1.53% | 2.55% | 750,000 | 600,000 | 400.00% | 31,417,500 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.48% | 2.26% | 725,000 | 725,000 | 100.00% | 30,370,250 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 1.43% | 0.10% | 702,607 | 160,234 | 29.54% | 29,432,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.27% | 0.00% | 624,104 | 156,557 | 33.48% | 26,148,387 | Jun 30, 2024 |
| BVF INC/IL | 0.90% | 0.52% | 441,528 | -2,478,290 | -84.88% | 18,495,608 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.81% | 0.00% | 396,906 | 318,281 | 404.81% | 16,626,392 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.70% | 0.00% | 344,672 | -2,499 | -0.72% | 14,438,310 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 0.66% | 0.23% | 324,703 | 28,312 | 9.55% | 13,601,809 | Jun 30, 2024 |
Janux Therapeutics's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 18.69% of the company's total share outstanding, currently valued at $383.95M. The top 10 institutional shareholders own together 66.04% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 18.69% | 5.08% | 9,165,652 | - | - | 383,949,162 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 1.53% | 2.55% | 750,000 | 600,000 | 400.00% | 31,417,500 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.14% | 2.54% | 1,050,000 | 300,000 | 40.00% | 43,984,500 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 3.19% | 2.51% | 1,564,452 | 1,564,452 | 100.00% | 65,534,894 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 6.08% | 2.48% | 2,979,828 | -1,295,725 | -30.31% | 124,824,995 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.48% | 2.26% | 725,000 | 725,000 | 100.00% | 30,370,250 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 3.00% | 1.88% | 1,469,818 | 1,469,818 | 100.00% | 61,570,676 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.71% | 1.50% | 840,219 | 455,974 | 118.67% | 35,196,774 | Jun 30, 2024 |
| RATAN CAPITAL MANAGEMENT LP | 0.22% | 1.34% | 105,757 | 85,757 | 428.79% | 4,430,160 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.19% | 1.14% | 92,949 | -28,693 | -23.59% | 3,893,634 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.10% | 0.66% | 50,000 | 50,000 | 100.00% | 2,094,500 | Jun 30, 2024 |
| BVF INC/IL | 0.90% | 0.52% | 441,528 | -2,478,290 | -84.88% | 18,495,608 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 0.08% | 0.47% | 40,000 | 40,000 | 100.00% | 1,675,600 | Jun 30, 2024 |
| OVATA CAPITAL MANAGEMENT LTD | 0.04% | 0.46% | 20,000 | -20,000 | -50.00% | 837,800 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.22% | 0.43% | 106,847 | 2,347 | 2.25% | 4,475,821 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.09% | 0.40% | 45,052 | -135,155 | -75.00% | 1,887,228 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.11% | 0.38% | 55,618 | -355 | -0.63% | 2,329,838 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.05% | 0.36% | 23,332 | 23,332 | 100.00% | 977,377 | Jun 30, 2024 |
| HARVEST MANAGEMENT LLC | 0.02% | 0.31% | 9,700 | 9,700 | 100.00% | 406,333 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 0.66% | 0.23% | 324,703 | 28,312 | 9.55% | 13,601,809 | Jun 30, 2024 |
The largest Janux Therapeutics shareholder by % of total assets is RA CAPITAL MANAGEMENT, L.P.. The company owns 9.17M shares of Janux Therapeutics (JANX), representing 5.08% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 3.19% | 2.51% | 1,564,452 | 1,564,452 | 100.00% | 65,534,894 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 3.00% | 1.88% | 1,469,818 | 1,469,818 | 100.00% | 61,570,676 | Jun 30, 2024 |
| STATE STREET CORP | 2.86% | 0.00% | 1,401,234 | 1,001,767 | 250.78% | 58,697,692,000 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.48% | 2.26% | 725,000 | 725,000 | 100.00% | 30,370,250 | Jun 30, 2024 |
| BLACKROCK INC. | 4.78% | 0.00% | 2,344,007 | 650,016 | 38.37% | 98,190,453 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 1.53% | 2.55% | 750,000 | 600,000 | 400.00% | 31,417,500 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.71% | 1.50% | 840,219 | 455,974 | 118.67% | 35,196,774 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.81% | 0.00% | 396,906 | 318,281 | 404.81% | 16,626,392 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.14% | 2.54% | 1,050,000 | 300,000 | 40.00% | 43,984,500 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.61% | 0.12% | 300,825 | 270,977 | 907.86% | 12,601,559 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.51% | 0.00% | 252,358 | 232,762 | 1187.80% | 10,572,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.18% | 0.00% | 1,561,758 | 203,798 | 15.01% | 65,422,042 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 1.43% | 0.10% | 702,607 | 160,234 | 29.54% | 29,432,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.27% | 0.00% | 624,104 | 156,557 | 33.48% | 26,148,387 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 0.41% | 0.22% | 203,000 | 153,000 | 306.00% | 8,503,670 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.28% | 0.01% | 136,430 | 136,430 | 100.00% | 5,715,053 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.27% | 0.01% | 133,000 | 133,000 | 100.00% | 5,571,370 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.24% | 0.00% | 119,395 | 95,854 | 407.18% | 5,001,457 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.49% | 0.07% | 242,531 | 89,810 | 58.81% | 10,159,622 | Jun 30, 2024 |
| RATAN CAPITAL MANAGEMENT LP | 0.22% | 1.34% | 105,757 | 85,757 | 428.79% | 4,430,160 | Jun 30, 2024 |
As of Jun 30 2024, Janux Therapeutics's largest institutional buyer is PARADIGM BIOCAPITAL ADVISORS LP. The company purchased 1.56M stocks of JANX, valued at $65.53M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | 0.90% | 0.52% | 441,528 | -2,478,290 | -84.88% | 18,495,608 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 6.08% | 2.48% | 2,979,828 | -1,295,725 | -30.31% | 124,824,995 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | - | - | - | -1,000,000 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.75% | 0.18% | 2,327,896 | -447,776 | -16.13% | 97,515,563 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -191,055 | -100.00% | - | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 3.67% | 0.04% | 1,801,843 | -163,703 | -8.33% | 75,389,599 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.09% | 0.40% | 45,052 | -135,155 | -75.00% | 1,887,228 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.21% | 0.01% | 103,601 | -121,119 | -53.90% | 4,339,846 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.11% | 0.20% | 55,500 | -102,300 | -64.83% | 2,324,895 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -92,899 | -100.00% | - | Jun 30, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | - | - | - | -64,500 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -52,300 | -100.00% | - | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | - | - | - | -47,949 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.17% | 0.00% | 81,798 | -39,433 | -32.53% | 3,426,528 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.19% | 1.14% | 92,949 | -28,693 | -23.59% | 3,893,634 | Jun 30, 2024 |
| CERITY PARTNERS LLC | - | - | - | -21,431 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.01% | 0.00% | 5,627 | -21,428 | -79.20% | 235,715 | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | - | - | - | -21,352 | -100.00% | - | Jun 30, 2024 |
| OVATA CAPITAL MANAGEMENT LTD | 0.04% | 0.46% | 20,000 | -20,000 | -50.00% | 837,800 | Jun 30, 2024 |
As of Jun 30 2024, Janux Therapeutics's biggest institutional seller is BVF INC/IL. The company sold -2.48M shares of JANX, valued at $18.50M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 3.19% | 2.51% | 1,564,452 | 1,564,452 | 100.00% | 65,534,894 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 3.00% | 1.88% | 1,469,818 | 1,469,818 | 100.00% | 61,570,676 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.48% | 2.26% | 725,000 | 725,000 | 100.00% | 30,370,250 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.28% | 0.01% | 136,430 | 136,430 | 100.00% | 5,715,053 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.27% | 0.01% | 133,000 | 133,000 | 100.00% | 5,571,370 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.16% | 0.01% | 77,246 | 77,246 | 100.00% | 3,235,835 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.11% | 0.01% | 55,212 | 55,212 | 100.00% | 2,312,831 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.10% | 0.66% | 50,000 | 50,000 | 100.00% | 2,094,500 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 0.08% | 0.47% | 40,000 | 40,000 | 100.00% | 1,675,600 | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.07% | 0.00% | 35,181 | 35,181 | 100.00% | 1,473,732 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.07% | 0.03% | 33,516 | 33,516 | 100.00% | 1,403,985 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.05% | 0.36% | 23,332 | 23,332 | 100.00% | 977,377 | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | 0.04% | 0.00% | 19,800 | 19,800 | 100.00% | 829,422 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.04% | 0.01% | 19,500 | 19,500 | 100.00% | 816,855 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 15,085 | 15,085 | 100.00% | 631,911 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.03% | 0.00% | 14,399 | 14,399 | 100.00% | 603,174 | Jun 30, 2024 |
| PROFUND ADVISORS LLC | 0.03% | 0.02% | 14,274 | 14,274 | 100.00% | 597,938 | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.02% | 0.00% | 12,220 | 12,220 | 100.00% | 511,896 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.02% | 0.00% | 11,541 | 11,541 | 100.00% | 483,452 | Jun 30, 2024 |
| PARKWOOD LLC | 0.02% | 0.06% | 11,390 | 11,390 | 100.00% | 477,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 11,043 | 11,043 | 100.00% | 458,084 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.02% | 0.00% | 10,700 | 10,700 | 100.00% | 448,223 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.02% | 0.07% | 10,142 | 10,142 | 100.00% | 424,848 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.02% | 0.00% | 10,034 | 10,034 | 100.00% | 420,324 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.02% | 0.01% | 9,980 | 9,980 | 100.00% | 418,062 | Jun 30, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | 0.02% | 0.02% | 9,723 | 9,723 | 100.00% | 407,296 | Jun 30, 2024 |
| HARVEST MANAGEMENT LLC | 0.02% | 0.31% | 9,700 | 9,700 | 100.00% | 406,333 | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | 0.02% | 0.00% | 9,500 | 9,500 | 100.00% | 397,955 | Jun 30, 2024 |
| AMUNDI | 0.02% | 0.00% | 9,409 | 9,409 | 100.00% | 362,247 | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.02% | 0.00% | 7,890 | 7,890 | 100.00% | 330,512 | Jun 30, 2024 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | 0.02% | 0.00% | 7,598 | 7,598 | 100.00% | 318,280 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.01% | 0.01% | 7,023 | 7,023 | 100.00% | 294,193 | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | 0.01% | 0.00% | 5,784 | 5,784 | 100.00% | 242,292 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.01% | 0.00% | 5,647 | 5,647 | 100.00% | 236,552,000 | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.01% | 0.03% | 5,600 | 5,600 | 100.00% | 234,584 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 0.01% | 0.01% | 5,400 | 5,400 | 100.00% | 226,206 | Jun 30, 2024 |
| DNB ASSET MANAGEMENT AS | 0.01% | 0.00% | 5,273 | 5,273 | 100.00% | 220,886 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 5,125 | 5,125 | 100.00% | 214,686 | Jun 30, 2024 |
| FORA CAPITAL, LLC | 0.01% | 0.02% | 4,858 | 4,858 | 100.00% | 203,502 | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 0.01% | 0.00% | 3,609 | 3,609 | 100.00% | 151,181,000 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.01% | 0.00% | 2,900 | 2,900 | 100.00% | 121,481 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.01% | 0.00% | 2,700 | 2,700 | 100.00% | 113,103 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.00% | 0.04% | 2,137 | 2,137 | 100.00% | 89,519 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | 0.00% | 0.00% | 1,800 | 1,800 | 100.00% | 75,402 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.00% | 0.10% | 1,649 | 1,649 | 100.00% | 69,077 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 1,548 | 1,548 | 100.00% | 62,446 | Jun 30, 2024 |
| PLATO INVESTMENT MANAGEMENT LTD | 0.00% | 0.00% | 999 | 999 | 100.00% | 41,848 | Jun 30, 2024 |
| CLEAR STREET MARKETS LLC | 0.00% | 0.01% | 700 | 700 | 100.00% | 29,000 | Jun 30, 2024 |
| FNY INVESTMENT ADVISERS, LLC | 0.00% | 0.02% | 650 | 650 | 100.00% | 27,000 | Jun 30, 2024 |
| PACER ADVISORS, INC. | 0.00% | - | 439 | 439 | 100.00% | 18,390 | Jun 30, 2024 |
| BFSG, LLC | 0.00% | 0.00% | 400 | 400 | 100.00% | 16,756 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.00% | 0.00% | 381 | 381 | 100.00% | 15,960,000 | Jun 30, 2024 |
| CULLEN/FROST BANKERS, INC. | 0.00% | 0.00% | 169 | 169 | 100.00% | 7,079 | Jun 30, 2024 |
| COMERICA BANK | 0.00% | - | 61 | 61 | 100.00% | 2,555 | Jun 30, 2024 |
| ABICH FINANCIAL WEALTH MANAGEMENT LLC | - | 0.00% | 20 | 20 | 100.00% | 838 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 10 | 10 | 100.00% | 419 | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | - | - | 10 | 10 | 100.00% | 419 | Jun 30, 2024 |
Janux Therapeutics's largest new institutional shareholder by number of shares is PARADIGM BIOCAPITAL ADVISORS LP, purchased 1.56M shares, valued at $65.53M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | - | - | - | -1,000,000 | -100.00% | - | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -191,055 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -92,899 | -100.00% | - | Jun 30, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | - | - | - | -64,500 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -52,300 | -100.00% | - | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | - | - | - | -47,949 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
| CERITY PARTNERS LLC | - | - | - | -21,431 | -100.00% | - | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | - | - | - | -21,352 | -100.00% | - | Jun 30, 2024 |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | - | - | - | -14,174 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -10,600 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -8,524 | -100.00% | - | Jun 30, 2024 |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | - | - | - | -8,464 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -6,909 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -6,892 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -6,808 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -5,784 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,004 | -100.00% | - | Jun 30, 2024 |
Janux Therapeutics's largest sold out institutional shareholder by shares sold is RTW INVESTMENTS, LP, sold -1.00M shares, valued at -, as of undefined.
Janux Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY ADVISOR SERIES VII | 0.09% | 741,585 | -144,200 | -16.28% | Jan 31, 2024 |
| Zacks Trust | 0.07% | 6,289 | 6,289 | - | Feb 29, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.05% | 60,000 | 60,000 | - | Mar 28, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.04% | 1,248,128 | 123,419 | 10.97% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.04% | 102,800 | 22,800 | 28.50% | Mar 31, 2024 |
| Humankind Benefit Corp | 0.03% | 622 | 150 | 31.78% | Dec 31, 2023 |
| SARATOGA ADVANTAGE TRUST | 0.02% | 1,461 | 1,461 | - | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 264,328 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 12,324 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.02% | 1,740 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 966,699 | 288,351 | 42.51% | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 888,403 | -490,534 | -35.57% | Jan 31, 2024 |
| FIDELITY CONTRAFUND | 0.01% | 447,400 | 447,400 | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 29,586 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 228,000 | 68,000 | 42.50% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 53,484 | 52,500 | 5335.37% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,549 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 82,900 | 37,900 | 84.22% | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 24,410 | 24,410 | - | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,143,580 | 73,493 | 6.87% | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 19,057 | 5,557 | 41.16% | Jan 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 557,857 | -11,819 | -2.07% | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 258 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 46,141 | -2,609 | -5.35% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 188,329 | 9,988 | 5.60% | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 16,711 | 2,676 | 19.07% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 14,042 | - | - | Feb 29, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 1,578 | 1,578 | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,706 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 15,740 | 8,396 | 114.32% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 4,716 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 55,078 | 19,585 | 55.18% | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 30,715 | -5,611 | -15.45% | Mar 28, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 12,794 | 12,474 | 3898.13% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 5,663 | -1,571 | -21.72% | Mar 31, 2024 |
| Global X Funds | 0.00% | 7,432 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 30,800 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 776 | -86 | -9.98% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 13,666 | 13,666 | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 14,514 | 5,503 | 61.07% | Feb 29, 2024 |
| LORD ABBETT SERIES FUND INC | 0.00% | 7,388 | 7,388 | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 6,100 | 200 | 3.39% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 205 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 8,784 | -628 | -6.67% | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 72,219 | 23,803 | 49.16% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 870,034 | -16,727 | -1.89% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,100 | 34 | 3.19% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 158 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 75,331 | 6,798 | 9.92% | Feb 29, 2024 |
| Guardian Variable Products Trust | 0.00% | 600 | 600 | - | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 273 | 273 | - | Mar 28, 2024 |
| PROSHARES TRUST | 0.00% | 5,985 | 3,753 | 168.15% | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 10,364 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 6,637 | -27 | -0.41% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,674 | 217 | 8.83% | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 61,225 | 8,582 | 16.30% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 78 | - | - | Dec 31, 2023 |
| Fidelity Rutland Square Trust II | 0.00% | 23,440 | 23,440 | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,159 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 500 | -200 | -28.57% | Mar 28, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 99 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,822 | 527 | 15.99% | Jan 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 300 | 300 | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 5,457 | 4,290 | 367.61% | Jan 31, 2024 |
| ProFunds | 0.00% | 134 | -11 | -7.59% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 11,971 | 3,169 | 36.00% | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,127 | 685 | 154.98% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 10 | - | - | Dec 31, 2023 |
| ALLSPRING FUNDS TRUST | 0.00% | 3,688 | -10,380 | -73.78% | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 5,711 | -1,881 | -24.78% | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 14,400 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,959 | -8 | -0.41% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 5,363 | 1,300 | 32.00% | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 600 | 900 | -300.00% | Mar 31, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 5,154 | 5,154 | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,216 | 1,101 | 957.39% | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 7,119 | -662 | -8.51% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 12,558 | -406 | -3.13% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 10,603 | 3,995 | 60.46% | Mar 31, 2024 |
| FIDELITY HASTINGS STREET TRUST | 0.00% | 11,800 | 11,800 | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 6,844 | 203 | 3.06% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,365 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 92 | 35 | 61.40% | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 10,049 | 7,249 | 258.89% | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,981 | -236 | -10.65% | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 2,333 | -3,559 | -60.40% | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,046 | -354 | -14.75% | Jan 31, 2024 |
| FIDELITY SUMMER STREET TRUST | 0.00% | 104 | - | - | Mar 31, 2024 |
Janux Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY ADVISOR SERIES VII", owning 741.59K shares, compromising 0.09% of its total assets.
Janux Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 52 | -58.06% |
| 31 Mar, 24 | 124 | 87.88% |
| 31 Dec, 23 | 66 | 11.86% |
| 30 Sep, 23 | 59 | 3.51% |
| 30 Jun, 23 | 57 | 14.00% |
| 31 Mar, 23 | 50 | -3.85% |
| 31 Dec, 22 | 52 | 6.12% |
| 30 Sep, 22 | 49 | 13.95% |
| 30 Jun, 22 | 43 | -8.51% |
| 31 Mar, 22 | 47 | 2.17% |
| 31 Dec, 21 | 46 | 2.22% |
| 30 Sep, 21 | 45 | 55.17% |
| 30 Jun, 21 | 29 | - |
As of 30 Jun 24, 52 institutions are holding Janux Therapeutics's shares, representing a decrease of -58.06% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 1,874,019 | -95.57% |
| 31 Mar, 24 | 42,293,771 | 26.24% |
| 31 Dec, 23 | 33,501,724 | -4.59% |
| 30 Sep, 23 | 35,112,153 | 14.57% |
| 30 Jun, 23 | 30,647,743 | 0.35% |
| 31 Mar, 23 | 30,541,932 | 5.48% |
| 31 Dec, 22 | 28,955,107 | -2.04% |
| 30 Sep, 22 | 29,559,356 | 2.24% |
| 30 Jun, 22 | 28,912,124 | 1.84% |
| 31 Mar, 22 | 28,388,595 | 3.24% |
| 31 Dec, 21 | 27,497,049 | 3.77% |
| 30 Sep, 21 | 26,499,215 | 7.10% |
| 30 Jun, 21 | 24,743,246 | - |
Janux Therapeutics (JANX) has 1.87M shares outstanding as of 30 Jun 24, down -95.57% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 3.82% | 0.04% |
| 31 Mar, 24 | 96.09% | 1.79% |
| 31 Dec, 23 | 73.29% | 1.04% |
| 30 Sep, 23 | 83.93% | 1.56% |
| 30 Jun, 23 | 73.38% | 1.37% |
| 31 Mar, 23 | 73.13% | 1.50% |
| 31 Dec, 22 | 69.82% | 1.38% |
| 30 Sep, 22 | 71.18% | 1.46% |
| 30 Jun, 22 | 69.75% | 1.48% |
| 31 Mar, 22 | 68.71% | 1.54% |
| 31 Dec, 21 | 66.73% | 1.61% |
| 30 Sep, 21 | 64.31% | 1.78% |
| 30 Jun, 21 | 60.04% | - |
As of 30 Jun 24, Janux Therapeutics is held by 3.82% institutional shareholders, representing a 0.04% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 33 | -61.63% |
| 31 Mar, 24 | 86 | 109.76% |
| 31 Dec, 23 | 41 | 28.13% |
| 30 Sep, 23 | 32 | 6.67% |
| 30 Jun, 23 | 30 | - |
| 31 Mar, 23 | 30 | 20.00% |
| 31 Dec, 22 | 25 | 13.64% |
| 30 Sep, 22 | 22 | 29.41% |
| 30 Jun, 22 | 17 | -39.29% |
| 31 Mar, 22 | 28 | 12.00% |
| 31 Dec, 21 | 25 | -24.24% |
| 30 Sep, 21 | 33 | 13.79% |
| 30 Jun, 21 | 29 | - |
33 institutional shareholders have increased their position in JANX stock as of 30 Jun 24 compared to 86 in the previous quarter (a -61.63% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -64.29% |
| 31 Mar, 24 | 28 | 154.55% |
| 31 Dec, 23 | 11 | -31.25% |
| 30 Sep, 23 | 16 | 14.29% |
| 30 Jun, 23 | 14 | 27.27% |
| 31 Mar, 23 | 11 | -8.33% |
| 31 Dec, 22 | 12 | -7.69% |
| 30 Sep, 22 | 13 | -13.33% |
| 30 Jun, 22 | 15 | 50.00% |
| 31 Mar, 22 | 10 | 11.11% |
| 31 Dec, 21 | 9 | 12.50% |
| 30 Sep, 21 | 8 | - |
| 30 Jun, 21 | - | - |
10 institutional shareholders have reduced their position in JANX stock as of 30 Jun 24 compared to 28 in the previous quarter (a -64.29% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 52 | -58.06% | 1,874,019 | -95.57% | 3.82% | 0.04% | 33 | -61.63% | 10 | -64.29% |
| 31 Mar, 24 | 124 | 87.88% | 42,293,771 | 26.24% | 96.09% | 1.79% | 86 | 109.76% | 28 | 154.55% |
| 31 Dec, 23 | 66 | 11.86% | 33,501,724 | -4.59% | 73.29% | 1.04% | 41 | 28.13% | 11 | -31.25% |
| 30 Sep, 23 | 59 | 3.51% | 35,112,153 | 14.57% | 83.93% | 1.56% | 32 | 6.67% | 16 | 14.29% |
| 30 Jun, 23 | 57 | 14.00% | 30,647,743 | 0.35% | 73.38% | 1.37% | 30 | - | 14 | 27.27% |
| 31 Mar, 23 | 50 | -3.85% | 30,541,932 | 5.48% | 73.13% | 1.50% | 30 | 20.00% | 11 | -8.33% |
| 31 Dec, 22 | 52 | 6.12% | 28,955,107 | -2.04% | 69.82% | 1.38% | 25 | 13.64% | 12 | -7.69% |
| 30 Sep, 22 | 49 | 13.95% | 29,559,356 | 2.24% | 71.18% | 1.46% | 22 | 29.41% | 13 | -13.33% |
| 30 Jun, 22 | 43 | -8.51% | 28,912,124 | 1.84% | 69.75% | 1.48% | 17 | -39.29% | 15 | 50.00% |
| 31 Mar, 22 | 47 | 2.17% | 28,388,595 | 3.24% | 68.71% | 1.54% | 28 | 12.00% | 10 | 11.11% |
| 31 Dec, 21 | 46 | 2.22% | 27,497,049 | 3.77% | 66.73% | 1.61% | 25 | -24.24% | 9 | 12.50% |
| 30 Sep, 21 | 45 | 55.17% | 26,499,215 | 7.10% | 64.31% | 1.78% | 33 | 13.79% | 8 | - |
| 30 Jun, 21 | 29 | - | 24,743,246 | - | 60.04% | - | 29 | - | - | - |
Janux Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Janux Therapeutics's stock was made by Dobek Maria on Aug 09 2024, selling 6,672 shares at $4.21 per share (valued at $28.08K).
Janux Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 12 | 5 | 240.00% |
| Q2 2024 | 16 | 8 | 200.00% |
| Q1 2024 | 12 | 10 | 120.00% |
| Q4 2023 | 3 | - | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 8 | - | - |
| Q1 2023 | 6 | 1 | 600.00% |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 13 | - | - |
| Q1 2022 | 6 | - | - |
| Q4 2021 | - | 12 | - |
| Q3 2021 | 2 | 1 | 200.00% |
| Q2 2021 | 39 | 43 | 90.70% |
12 total buy trades, and 5 total sell trades (buy/sell ratio of 2.40%) were made by Janux Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 8 | - |
| Q1 2024 | 1 | - | - |
| Q4 2023 | 3 | - | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 12 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 10 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Janux Therapeutics's stocks.
Janux Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| CYT | Cyteir Therapeutics, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| FENC | Fennec Pharmaceuticals Inc. |
| CSBR | Champions Oncology, Inc. |
| ANTX | AN2 Therapeutics, Inc. |
| KROS | Keros Therapeutics, Inc. |
| HRMY | Harmony Biosciences Holdings, Inc. |
| MNOV | MediciNova, Inc. |
| RZLT | Rezolute, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| ADAG | Adagene Inc. |
| MOLN | Molecular Partners AG |
| ELYM | Eliem Therapeutics, Inc. |
JANX Ownership FAQ
Who Owns Janux Therapeutics?
Janux Therapeutics is owned by institutional shareholders (3.82%), insiders (9.42%), and public (86.76%). The largest institutional shareholder of Janux Therapeutics is RA CAPITAL MANAGEMENT, L.P. (18.69% of total shares) and the top mutual fund owner is FIDELITY ADVISOR SERIES VII (0.09% of total shares).
Who are the major institutional shareholders of Janux Therapeutics?
Janux Therapeutics's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., FMR LLC, ORBIMED ADVISORS LLC, BLACKROCK INC., and ADAGE CAPITAL PARTNERS GP, L.L.C.. The top five shareholders own together 50.14% of the company's share outstanding.
How many Janux Therapeutics shareholders are there?
As of Jun 2024, there are 52 institutional shareholders of Janux Therapeutics.
What percentage of Janux Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 9.17M shares of Janux Therapeutics, representing 18.69% of the company's total shares outstanding, valued at $383.95M (as of Jun 2024).
What percentage of Janux Therapeutics is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 7.78M shares of Janux Therapeutics (JANX), compromising 15.86% of the company, valued at $325.8M.
What percentage of Janux Therapeutics is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC is the third largest holder of Janux Therapeutics. The company owns 2.98M of the company's shares outstanding (worth $124.82M).